With development capability for both small and large biomolecules, we provide complete CMC services for oral, inhalation, and sterile products from preformulation through clinical supply, including scale-up and technology transfer to our commercial manufacturing facilities. Our rigorous physiocochemical characterization of APIs - a regulatory expectation - can help you avert situations that result from failure to detect polymorphic forms and poor salt selection. Supported by integrated project management, our balanced preformulation approach can ensure a consistent quality of product from discovery to clinic, and beyond.
Learn more about how we can help your preformulation goals in these areas:
We provide studies necessary to elucidate the drug substance candidate with optimal physicochemical properties.